Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Breast Neoplasms 39Colonic Neoplasms 14Colorectal Neoplasms 13Neoplasms 12Rectal Neoplasms 11Prostatic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Obesity 8Motor Activity 8Lung Neoplasms 8Endometrial Neoplasms 8Tobacco Use Disorder 6Small Cell Lung Carcinoma 6Overweight 6Depression 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Urinary Bladder Neoplasms 4Sexuality 4Sexual Dysfunction, Physiological 4Leukemia 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Intraductal, Noninfiltrating 4Body Weight Changes 4

Interventions

pembrolizumab 157Gemcitabine 140Capecitabine 123Paclitaxel 121Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Docetaxel 98Leucovorin 97Cisplatin 90Radiosurgery 88Irinotecan 88Carboplatin 86Cyclophosphamide 72Cetuximab 72Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Counseling × Clear all
NCT05847686 2025-11-05

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

University of Washington

Phase 1/2 Completed
55 enrolled 11 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT00244868 2013-01-29

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

Fox Chase Cancer Center

Phase 3 Completed
720 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡